Pharmaceutical Supply – Guaifenesin and Dextromethorphan Hydrobromide

The contract involves the manufacture and supply of 16 units of Guaifenesin and Dextromethorphan Hydrobromide, identified by NDC 63824-0056-32 and NSN 6505015603527, an over-the-counter medication used to treat cough and cold symptoms. The product is being procured for delivery to a U.S. Navy vessel, indicating it will support medical needs aboard naval vessels in operational environments. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, and is administered by the Defense Logistics Agency on behalf of the Department of Defense. While specific delivery timelines and payment terms are not provided, the posting date of July 20, 2026, suggests this is a forward-looking requirement, likely part of routine medical inventory replenishment for military health services. The procurement is not subject to any set-aside provisions, meaning it is open to all qualified contractors without restriction based on business size or ownership status.